Hua Qin He

US Patent:

8153162, Apr 10, 2012

Filed:

Sep 27, 2006

Appl. No.:

11/528980

Inventors:

Scheffer Tseng - Pinecrest FL, US
Hua He - Miami FL, US
Wei Li - Songgang Town, CN

Assignee:

Tissuetech, Inc. - Miami FL

International Classification:

A61K 35/50

US Classification:

424583, 424574, 424400

Abstract:

Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.

US Patent:

8182840, May 22, 2012

Filed:

Sep 27, 2006

Appl. No.:

11/528902

Inventors:

Scheffer Tseng - Pinecrest FL, US
Hua He - Miami FL, US
Wei Li - Songgang Town, CN

Assignee:

Tissue Tech, Inc. - Miami FL

International Classification:

A61K 35/50

US Classification:

424583, 424574, 424400

Abstract:

Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.

US Patent:

8182841, May 22, 2012

Filed:

Sep 27, 2006

Appl. No.:

11/529658

Inventors:

Scheffer Tseng - Pinecrest FL, US
Hua He - Miami FL, US
Wei Li - Songgang Town, CN

Assignee:

Tissue Tech, Inc. - Miami FL

International Classification:

A61K 35/50

US Classification:

424583, 425574, 425400

Abstract:

Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.

US Patent:

8187639, May 29, 2012

Filed:

Sep 27, 2006

Appl. No.:

11/535924

Inventors:

Scheffer Tseng - Pinecrest FL, US
Hua He - Miami FL, US
Wei Li - Songgang Town, CN

Assignee:

Tissue Tech, Inc. - Miami FL

International Classification:

A61K 35/50

US Classification:

424583, 424574, 424400, 514 133

Abstract:

Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.

US Patent:

8420126, Apr 16, 2013

Filed:

Apr 23, 2012

Appl. No.:

13/453840

Inventors:

Scheffer Tseng - Pinecrest FL, US
Hua He - Miami FL, US
Wei Li - Songang Town, CN

Assignee:

Tissue Tech, Inc. - Miami FL

International Classification:

A61K 35/50

US Classification:

424583, 424400, 424574, 514 133

Abstract:

Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.

US Patent:

8440235, May 14, 2013

Filed:

Apr 23, 2012

Appl. No.:

13/453765

Inventors:

Scheffer Tseng - Pinecrest FL, US
Hua He - Miami FL, US
Wei Li - Songgang Town, CN

Assignee:

TissueTech, Inc. - Miami FL

International Classification:

A61K 35/50

US Classification:

424583, 424400, 424574

Abstract:

Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.

US Patent:

8455009, Jun 4, 2013

Filed:

Apr 23, 2012

Appl. No.:

13/453771

Inventors:

Scheffer Tseng - Pinecrest FL, US
Hua He - Miami FL, US
Wei Li - Songgang Town, CN

Assignee:

TissueTech, Inc. - Miami FL

International Classification:

A61K 35/50

US Classification:

424583, 424400, 424574

Abstract:

Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.

US Patent:

8460714, Jun 11, 2013

Filed:

Apr 3, 2012

Appl. No.:

13/438759

Inventors:

Scheffer Tseng - Pinecrest FL, US
Hua He - Miami FL, US
Wei Li - Guangdong, CN

Assignee:

TissueTech, Inc. - Miami FL

International Classification:

A61K 35/50

US Classification:

424583, 424400, 424574

Abstract:

Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.